VIM and lung cancer: Our results suggesting physical binding to circPTK2 to vimentin, which is distinguished from circPTK2 (hsa_circ_0008305), acting as a sponge for miR-429 / miR-200b-3p in non-small cell lung cancer cells and hereby inhibiting EMT in lung cancer cells [32].